Raphael Pharmaceutical (RAPH) Intangibles (2022 - 2024)

Raphael Pharmaceutical has disclosed Intangibles across 3 years of filings, most recently posting $2000.0 for Q2 2024.

• Intangibles for Q2 2024 came in at $2000.0, up 100.0% year-over-year; the trailing twelve-month figure through Jun 2024 was $2000.0 (up 100.0% YoY), and the FY2023 annual result was $2000.0, changed 0.0% from the prior year.
• Intangibles came in at $2000.0 for Q2 2024 at Raphael Pharmaceutical, down from $3000.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $3000.0 in Q1 2024 to a low of $1000.0 in Q1 2023.
• The 3-year median for Intangibles is $2000.0 (2022), against an average of $1750.0.
• Across the five-year window, Intangibles plunged 50.0% in 2023 and surged 200.0% in 2024, its largest moves.
• Raphael Pharmaceutical's Intangibles stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024.
• The last three Intangibles figures came in at $2000.0 (Q2 2024), $3000.0 (Q1 2024), and $2000.0 (Q4 2023), per Business Quant data.